In summary, in this study, we examined the expression levels of APN and FoxO1 to explore the potential role of these two proteins in the pathology of type 1 diabetes-induced NAFLD. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.